US Stock MarketDetailed Quotes

VKTX Viking Therapeutics

Watchlist

52.940
-1.570-2.88%

Close Nov 29 13:00 ET

53.010
+0.070+0.13%

Post 17:01 ET

5.90BMarket Cap-56319P/E (TTM)

Viking Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

147.30%930.44M

139.81%942.26M

609.82%962.98M

132.87%362.08M

142.70%376.24M

132.61%392.92M

-26.63%135.66M

-23.07%155.49M

-Cash and cash equivalents

35.40%50.35M

-36.83%43.92M

965.13%195.58M

51.55%55.52M

26.45%37.19M

328.44%69.52M

47.44%18.36M

38.91%36.63M

-Short-term investments

159.57%880.09M

177.78%898.35M

554.21%767.4M

157.93%306.56M

169.92%339.06M

111.80%323.4M

-31.98%117.3M

-32.37%118.85M

Prepaid assets

1.98%4.48M

-39.48%3.32M

-72.50%2.72M

-67.78%2.62M

-56.64%4.39M

-49.84%5.49M

17.60%9.88M

4.33%8.14M

Other current assets

158.66%1.73M

-85.63%138K

-83.62%643K

-26.06%2.52M

--670K

--960K

--3.93M

451.05%3.41M

Total current assets

145.65%936.65M

136.80%945.72M

546.52%966.34M

119.84%367.23M

130.89%381.3M

122.04%399.37M

-22.68%149.47M

-20.66%167.04M

Non current assets

Net PPE

-7.25%1.11M

-23.25%977K

-21.84%1.05M

-20.59%1.13M

-19.41%1.2M

-18.40%1.27M

-17.52%1.35M

5,572.00%1.42M

-Gross PPE

-7.25%1.11M

-23.25%977K

-21.84%1.05M

-20.59%1.13M

-19.41%1.2M

-18.40%1.27M

-17.52%1.35M

5,572.00%1.42M

Non current deferred assets

-38.46%80K

556.25%105K

104.17%98K

178.95%106K

766.67%130K

-69.23%16K

-25.00%48K

-50.00%38K

Non current prepaid assets

39.39%46K

0.00%33K

Total non current assets

-9.10%1.24M

-15.66%1.12M

-17.10%1.18M

-15.04%1.27M

-11.32%1.36M

-19.64%1.32M

-17.47%1.43M

1,011.19%1.49M

Total assets

145.10%937.89M

136.30%946.84M

541.19%967.52M

118.65%368.49M

129.58%382.66M

120.76%400.69M

-22.63%150.9M

-20.00%168.53M

Liabilities

Current liabilities

Payables

-95.55%254K

97.65%11.09M

37.54%5.23M

-11.92%7.51M

81.76%5.71M

-8.08%5.61M

21.80%3.8M

490.65%8.53M

-accounts payable

-95.55%254K

97.65%11.09M

37.54%5.23M

-11.92%7.51M

81.76%5.71M

-8.08%5.61M

21.80%3.8M

490.65%8.53M

Current accrued expenses

238.32%24.95M

80.97%13.67M

135.85%27.22M

-13.84%11.3M

-30.56%7.38M

-11.37%7.55M

44.28%11.54M

79.52%13.11M

Current debt and capital lease obligation

50.47%480K

6.37%334K

6.47%329K

6.58%324K

6.69%319K

31.93%314K

106.00%309K

948.28%304K

-Current capital lease obligation

50.47%480K

6.37%334K

6.47%329K

6.58%324K

6.69%319K

31.93%314K

106.00%309K

948.28%304K

Current liabilities

91.61%25.69M

86.18%25.09M

109.43%32.77M

-12.81%19.14M

-4.67%13.41M

-9.32%13.48M

38.88%15.65M

150.02%21.95M

Non current liabilities

Long term debt and capital lease obligation

-25.83%755K

-30.36%766K

-27.86%852K

-25.71%936K

-23.86%1.02M

-22.21%1.1M

-20.74%1.18M

--1.26M

-Long term capital lease obligation

-25.83%755K

-30.36%766K

-27.86%852K

-25.71%936K

-23.86%1.02M

-22.21%1.1M

-20.74%1.18M

--1.26M

Total non current liabilities

-25.83%755K

-30.36%766K

-27.86%852K

-25.71%936K

-23.86%1.02M

-22.21%1.1M

-20.74%1.18M

--1.26M

Total liabilities

83.32%26.44M

77.38%25.86M

99.80%33.63M

-13.51%20.07M

-6.33%14.42M

-10.44%14.58M

31.92%16.83M

164.38%23.21M

Shareholders'equity

Share capital

0.00%1K

-common stock

0.00%1K

-Preferred stock

--0

Retained earnings

-28.06%-452.49M

-29.25%-427.55M

-30.08%-405.3M

-29.41%-377.94M

-29.67%-353.34M

-28.86%-330.81M

-30.21%-311.58M

-30.86%-292.05M

Paid-in capital

86.80%1.36B

86.38%1.35B

195.94%1.34B

64.74%733.55M

68.69%729.28M

68.39%724.75M

5.83%453.06M

4.62%445.27M

Less: Treasury stock

--0

0.00%6.8M

32.69%6.8M

--6.8M

Gains losses not affecting retained earnings

280.33%1.63M

-118.46%-2.27M

-158.74%-1.6M

64.70%-389K

48.61%-905K

36.93%-1.04M

56.20%-618K

-100.73%-1.1M

Total stockholders'equity

147.51%911.45M

138.52%920.98M

596.60%933.89M

139.76%348.42M

143.41%368.24M

133.68%386.12M

-26.45%134.07M

-28.02%145.32M

Total equity

147.51%911.45M

138.52%920.98M

596.60%933.89M

139.76%348.42M

143.41%368.24M

133.68%386.12M

-26.45%134.07M

-28.02%145.32M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	147.30%930.44M	139.81%942.26M	609.82%962.98M	132.87%362.08M	132.87%362.08M	142.70%376.24M	132.61%392.92M	-26.63%135.66M	-23.07%155.49M	-23.07%155.49M
-Cash and cash equivalents	35.40%50.35M	-36.83%43.92M	965.13%195.58M	51.55%55.52M	51.55%55.52M	26.45%37.19M	328.44%69.52M	47.44%18.36M	38.91%36.63M	38.91%36.63M
-Short-term investments	159.57%880.09M	177.78%898.35M	554.21%767.4M	157.93%306.56M	157.93%306.56M	169.92%339.06M	111.80%323.4M	-31.98%117.3M	-32.37%118.85M	-32.37%118.85M
Prepaid assets	1.98%4.48M	-39.48%3.32M	-72.50%2.72M	-67.78%2.62M	-67.78%2.62M	-56.64%4.39M	-49.84%5.49M	17.60%9.88M	4.33%8.14M	4.33%8.14M
Other current assets	158.66%1.73M	-85.63%138K	-83.62%643K	-26.06%2.52M	-26.06%2.52M	--670K	--960K	--3.93M	451.05%3.41M	451.05%3.41M
Total current assets	145.65%936.65M	136.80%945.72M	546.52%966.34M	119.84%367.23M	119.84%367.23M	130.89%381.3M	122.04%399.37M	-22.68%149.47M	-20.66%167.04M	-20.66%167.04M
Non current assets
Net PPE	-7.25%1.11M	-23.25%977K	-21.84%1.05M	-20.59%1.13M	-20.59%1.13M	-19.41%1.2M	-18.40%1.27M	-17.52%1.35M	5,572.00%1.42M	5,572.00%1.42M
-Gross PPE	-7.25%1.11M	-23.25%977K	-21.84%1.05M	-20.59%1.13M	-20.59%1.13M	-19.41%1.2M	-18.40%1.27M	-17.52%1.35M	5,572.00%1.42M	5,572.00%1.42M
Non current deferred assets	-38.46%80K	556.25%105K	104.17%98K	178.95%106K	178.95%106K	766.67%130K	-69.23%16K	-25.00%48K	-50.00%38K	-50.00%38K
Non current prepaid assets	39.39%46K	0.00%33K	0.00%33K	0.00%33K	0.00%33K	0.00%33K	0.00%33K	0.00%33K	0.00%33K	0.00%33K
Total non current assets	-9.10%1.24M	-15.66%1.12M	-17.10%1.18M	-15.04%1.27M	-15.04%1.27M	-11.32%1.36M	-19.64%1.32M	-17.47%1.43M	1,011.19%1.49M	1,011.19%1.49M
Total assets	145.10%937.89M	136.30%946.84M	541.19%967.52M	118.65%368.49M	118.65%368.49M	129.58%382.66M	120.76%400.69M	-22.63%150.9M	-20.00%168.53M	-20.00%168.53M
Liabilities
Current liabilities
Payables	-95.55%254K	97.65%11.09M	37.54%5.23M	-11.92%7.51M	-11.92%7.51M	81.76%5.71M	-8.08%5.61M	21.80%3.8M	490.65%8.53M	490.65%8.53M
-accounts payable	-95.55%254K	97.65%11.09M	37.54%5.23M	-11.92%7.51M	-11.92%7.51M	81.76%5.71M	-8.08%5.61M	21.80%3.8M	490.65%8.53M	490.65%8.53M
Current accrued expenses	238.32%24.95M	80.97%13.67M	135.85%27.22M	-13.84%11.3M	-13.84%11.3M	-30.56%7.38M	-11.37%7.55M	44.28%11.54M	79.52%13.11M	79.52%13.11M
Current debt and capital lease obligation	50.47%480K	6.37%334K	6.47%329K	6.58%324K	6.58%324K	6.69%319K	31.93%314K	106.00%309K	948.28%304K	948.28%304K
-Current capital lease obligation	50.47%480K	6.37%334K	6.47%329K	6.58%324K	6.58%324K	6.69%319K	31.93%314K	106.00%309K	948.28%304K	948.28%304K
Current liabilities	91.61%25.69M	86.18%25.09M	109.43%32.77M	-12.81%19.14M	-12.81%19.14M	-4.67%13.41M	-9.32%13.48M	38.88%15.65M	150.02%21.95M	150.02%21.95M
Non current liabilities
Long term debt and capital lease obligation	-25.83%755K	-30.36%766K	-27.86%852K	-25.71%936K	-25.71%936K	-23.86%1.02M	-22.21%1.1M	-20.74%1.18M	--1.26M	--1.26M
-Long term capital lease obligation	-25.83%755K	-30.36%766K	-27.86%852K	-25.71%936K	-25.71%936K	-23.86%1.02M	-22.21%1.1M	-20.74%1.18M	--1.26M	--1.26M
Total non current liabilities	-25.83%755K	-30.36%766K	-27.86%852K	-25.71%936K	-25.71%936K	-23.86%1.02M	-22.21%1.1M	-20.74%1.18M	--1.26M	--1.26M
Total liabilities	83.32%26.44M	77.38%25.86M	99.80%33.63M	-13.51%20.07M	-13.51%20.07M	-6.33%14.42M	-10.44%14.58M	31.92%16.83M	164.38%23.21M	164.38%23.21M
Shareholders'equity
Share capital	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K
-common stock	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-28.06%-452.49M	-29.25%-427.55M	-30.08%-405.3M	-29.41%-377.94M	-29.41%-377.94M	-29.67%-353.34M	-28.86%-330.81M	-30.21%-311.58M	-30.86%-292.05M	-30.86%-292.05M
Paid-in capital	86.80%1.36B	86.38%1.35B	195.94%1.34B	64.74%733.55M	64.74%733.55M	68.69%729.28M	68.39%724.75M	5.83%453.06M	4.62%445.27M	4.62%445.27M
Less: Treasury stock	--0	--0	--0	0.00%6.8M	0.00%6.8M	0.00%6.8M	0.00%6.8M	32.69%6.8M	--6.8M	--6.8M
Gains losses not affecting retained earnings	280.33%1.63M	-118.46%-2.27M	-158.74%-1.6M	64.70%-389K	64.70%-389K	48.61%-905K	36.93%-1.04M	56.20%-618K	-100.73%-1.1M	-100.73%-1.1M
Total stockholders'equity	147.51%911.45M	138.52%920.98M	596.60%933.89M	139.76%348.42M	139.76%348.42M	143.41%368.24M	133.68%386.12M	-26.45%134.07M	-28.02%145.32M	-28.02%145.32M
Total equity	147.51%911.45M	138.52%920.98M	596.60%933.89M	139.76%348.42M	139.76%348.42M	143.41%368.24M	133.68%386.12M	-26.45%134.07M	-28.02%145.32M	-28.02%145.32M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

Investment Theme

Weight Loss Drugs

Intraday+0.87%